Kaposi Sarcoma
Kaposi Sarcoma is a rare cancer arising from the cells lining blood vessels and lymphatic vessels, often presenting as purplish or reddish skin lesions.
It may affect the skin, mucous membranes, or internal organs. Early diagnosis and management, especially in immunocompromised patients, is essential to prevent complications and control disease progression.
Causes and Risk Factors of Kaposi Sarcoma
Kaposi Sarcoma is associated with human herpesvirus 8 (HHV-8) and immune system suppression.
- HIV/AIDS: Weakened immunity increases susceptibility to KS.
- Immunosuppression Organ transplant recipients:
- Genetic and geographic factors: Certain populations are more prone to KS in endemic regions.
Symptoms and Clinical Features
Kaposi Sarcoma presents with distinct skin and systemic signs.
- Purple or reddish skin patches, nodules, or plaques
- Oral or mucosal involvement: May cause mouth or throat lesions
- Swelling in affected limbs due to lymphatic obstruction
- Possible organ involvement: lungs, liver, or gastrointestinal tract
Treatment Options for Kaposi Sarcoma
Management depends on disease extent and immune status.
- Antiretroviral therapy: For HIV-associated KS to improve immune function.
- Chemotherapy: Systemic or localized treatment for aggressive disease.
- Radiotherapy or surgical excision for localized lesions.
Why Choose Us for Kaposi Sarcoma
CureU Healthcare provides specialized oncology care, expert diagnosis, and individualized treatment plans to ensure optimal outcomes for KS patients.
Conclusion
Kaposi Sarcoma is a rare but manageable vascular cancer. Early detection and treatment at CureU Healthcare ensure comprehensive care and improved quality of life.
